Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125468431 | 12546843 | 1 | I | 20160214 | 20160704 | 20160711 | 20160711 | EXP | FR-ELI_LILLY_AND_COMPANY-FR201607000823 | ELI LILLY AND CO | 21.48 | YR | F | Y | 0.00000 | 20160711 | CN | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125468431 | 12546843 | 1 | PS | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Oral | 840 MG, SINGLE | U | U | 21427 | 840 | MG | CAPSULE | |||||
| 125468431 | 12546843 | 2 | SS | VALIUM | DIAZEPAM | 1 | Oral | 110 MG, SINGLE | U | U | 0 | 110 | MG | TABLET | |||||
| 125468431 | 12546843 | 3 | SS | TERCIAN /00759301/ | CYAMEMAZINE | 1 | Oral | 200 MG, SINGLE | U | U | 0 | 200 | MG | TABLET | |||||
| 125468431 | 12546843 | 4 | SS | SERESTA | OXAZEPAM | 1 | Oral | 800 MG, SINGLE | U | U | 0 | 800 | MG | CHEWABLE TABLET | |||||
| 125468431 | 12546843 | 5 | SS | LORAZEPAM. | LORAZEPAM | 1 | Oral | 30 MG, SINGLE | U | U | 0 | 30 | MG | TABLET | |||||
| 125468431 | 12546843 | 6 | SS | STILNOX | ZOLPIDEM TARTRATE | 1 | Oral | 14 DF, SINGLE | U | U | 0 | 14 | DF | CHEWABLE TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125468431 | 12546843 | 1 | Product used for unknown indication |
| 125468431 | 12546843 | 2 | Product used for unknown indication |
| 125468431 | 12546843 | 3 | Product used for unknown indication |
| 125468431 | 12546843 | 4 | Product used for unknown indication |
| 125468431 | 12546843 | 5 | Product used for unknown indication |
| 125468431 | 12546843 | 6 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125468431 | 12546843 | HO |
| 125468431 | 12546843 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125468431 | 12546843 | Coma | |
| 125468431 | 12546843 | Intentional overdose | |
| 125468431 | 12546843 | Intentional self-injury | |
| 125468431 | 12546843 | Scar | |
| 125468431 | 12546843 | Toxicity to various agents |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125468431 | 12546843 | 1 | 20160214 | 20160214 | 0 | |
| 125468431 | 12546843 | 2 | 20160214 | 20160214 | 0 | |
| 125468431 | 12546843 | 3 | 20160214 | 20160214 | 0 | |
| 125468431 | 12546843 | 4 | 20160214 | 20160214 | 0 | |
| 125468431 | 12546843 | 5 | 20160214 | 20160214 | 0 | |
| 125468431 | 12546843 | 6 | 20160214 | 20160214 | 0 |